Virudhunagar, India

Kathiravan Sindhuamuthan

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Biocon Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathiravan Sindhuamuthan. Retrieved from https://idiyas.com/inventor/kathiravan-sindhuamuthan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathiravan Sindhuamuthan: Innovator in GLP-1 Analogues Purification

Introduction

Kathiravan Sindhuamuthan is a notable inventor based in Virudhunagar, India. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of GLP-1 analogues. His work is essential for improving the quality and efficacy of diabetes medications.

Latest Patents

Sindhuamuthan holds a patent for the "Purification of GLP-1 analogues." This invention focuses on the purification of liraglutide using selective ion-pairing agents in reversed phase-high performance liquid chromatography. The method is designed to purify crude liraglutide from closely related impurities, enhancing the drug's safety and effectiveness.

Career Highlights

He is currently employed at Biocon Limited, a leading biopharmaceutical company. His role involves research and development, where he applies his expertise in purification techniques to advance therapeutic solutions. His innovative approach has contributed to the company's reputation for quality in biopharmaceuticals.

Collaborations

Sindhuamuthan collaborates with talented professionals in his field, including Ramachandran Ganesh and Onkar Prakash Santan. These collaborations foster a creative environment that drives innovation and enhances the development of new technologies.

Conclusion

Kathiravan Sindhuamuthan is a pioneering inventor whose work in the purification of GLP-1 analogues is making a significant impact in the pharmaceutical industry. His contributions are vital for the advancement of diabetes treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…